TRMT10A ‐Related Neurodevelopmental Disorder Without Metabolic Findings
Human Mutation · 2026-01 · 2026 (1)
DOI: 10.1155/humu/8058409 ↗Kurz gefasst
Fallbericht in der Zeitschrift Human Mutation, online erschienen am 22.05.2026. Verfasst von Döndü Ülker Üstebay und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Neurology, Faculty of Medicine, Bandırma Onyedi Eylül University, Balıkesir, Türkiye, bandirma.edu.tr. Hauptthemen laut MEDLINE: Neurodevelopmental Disorders, Methyltransferases, tRNA Methyltransferases. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
TRMT10A is a tRNA methyltransferase gene associated with a rare autosomal recessive disorder characterized by microcephaly, intellectual disability, epilepsy, short stature, and abnormalities in glucose metabolism. Although an increasing number of patients have been reported, the extent of phenotypic variability and genotype–phenotype correlations remains incompletely understood. We report a 15‐year‐old male presenting with microcephaly, intellectual disability, epilepsy, and short stature, without evidence of diabetes or other metabolic abnormalities at the time of evaluation. Neurodevelopmental delay was evident from early childhood, and electroencephalography revealed generalized epileptiform activity requiring treatment, whereas brain magnetic resonance imaging was normal. Exome sequencing identified a homozygous stop‐gained pathogenic (PVS1, PM2, and PM3) variant in TRMT10A (c.127C>T; p.Arg43Ter), which was confirmed by Sanger sequencing and showed segregation consistent with autosomal recessive inheritance. This case represents one of the rare reported TRMT10A ‐related syndrome patients in whom diabetes has not yet been documented. This observation highlights the clinical importance of establishing the diagnosis prior to the onset of diabetes, enabling anticipatory monitoring and timely intervention for potential metabolic complications. These findings underscore the importance of considering TRMT10A in the differential diagnosis of patients with microcephaly, intellectual disability, epilepsy, and growth abnormalities, and emphasize the need for longitudinal follow‐up to monitor for the possible later development of endocrine and metabolic manifestations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Neurology, Faculty of Medicine, Bandırma Onyedi Eylül University, Balıkesir, Türkiye, bandirma.edu.tr.
- Department of Medical Genetics, Faculty of Medicine, Balıkesir University, Balıkesir, Türkiye, balikesir.edu.tr.
- Department of Pediatrics, Faculty of Medicine, Bandırma Onyedi Eylül University, Bandırma, Türkiye, bandirma.edu.tr.
- Department of Child and Adolescent Psychiatry, Faculty of Medicine, Balıkesir University, Balıkesir, Türkiye, balikesir.edu.tr.
ORCID-Profile: Döndü Ülker Üstebay, İrem Aksu Şahin, Sefer Üstebay, Gül Ünsel Bolat, Hilmi Bolat
Zitieren
APA
Ülker Üstebay, D., Aksu Şahin, İ., Üstebay, S., Ünsel Bolat, G., & Bolat, H. (2026). TRMT10A ‐Related Neurodevelopmental Disorder Without Metabolic Findings. Human Mutation, 2026(1). https://doi.org/10.1155/humu/8058409
Vancouver
Ülker Üstebay D, Aksu Şahin İ, Üstebay S, Ünsel Bolat G, Bolat H. TRMT10A ‐Related Neurodevelopmental Disorder Without Metabolic Findings. Human Mutation. 2026;2026(1). doi:10.1155/humu/8058409
BibTeX
@article{lkerstebay2026,
author = {Ülker Üstebay, Döndü and Aksu Şahin, İrem and Üstebay, Sefer and Ünsel Bolat, Gül and Bolat, Hilmi},
title = {TRMT10A ‐Related Neurodevelopmental Disorder Without Metabolic Findings},
journal = {Human Mutation},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/humu/8058409}
}
EUVIMED